1. SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia;Barone;J Pharmacol Exp Ther,2001
2. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles;Bleakman;Neuropharmacology,1996
3. Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats;Borowicz;Pol J Pharmacol,2001
4. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice;Chapman;Epilepsy Res,1991
5. Glutamate antagonists have different effects on spontaneous locomotor activity in rats;Danysz;Pharmacol Biochem Behav,1994